Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up

Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00198341

Enrollment

1775

Registered

2005-09-20

Start date

2005-01-31

Completion date

2022-07-31

Last updated

2022-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small-Cell Lung Carcinoma

Keywords

Post-surgical Non-small cell lung cancer

Brief summary

The follow-up of patients operated on for lung cancer is heterogeneous. An intensive follow-up including routine clinic visits, chest X-rays, chest computed tomography (CT) scans and fiberoptic bronchoscopies might detect more small, potentially curable, recurrences and second cancers. However, as it appears in the American Society of Clinical Oncology (ASCO) recommendations, a large randomized study is necessary to evaluate the survival impact of such a follow-up strategy. This is the main objective of this IFCT-0302 study, which is a large randomized controlled study conducted in France comparing this intensive follow-up to a follow-up with only routine clinic visits and chest X-rays.

Interventions

PROCEDURERadiological Arm

Clinical Visit + X-Ray Chest

PROCEDUREScannographic arm

Clinical visit + X-Ray Chest + CT-Scan + Fibroscopy (for squamous cell)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* completely resected stage I, II, IIIa, and T4 due to satellite tumor nodule(s) N0-2 NSCLC

Exclusion criteria

* stage IIIb to IV NSCLC

Design outcomes

Primary

Measure	Time frame
Compare overall survival for each arm	6-month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026